Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | FAAH | O00519 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20803553 | 0.85 | TP53 (0.43) | TP53TDP1ALDH1A1TSHRFAAH | |
| SCHEMBL20786851 | 0.80 | ALDH1A1 (0.41) | TP53ALDH1A1TSHRMEN1POLB | |
| SCHEMBL29871077 | 0.78 | TP53 (0.46) | TP53TDP1ALDH1A1TSHRFAAH | |
| SCHEMBL9715865 | 0.78 | TP53 (0.46) | TP53TDP1ALDH1A1TSHRFAAH | |
| SCHEMBL9715903 | 0.78 | TP53 (0.46) | TP53TDP1ALDH1A1TSHRFAAH | |
| SCHEMBL611478 | 0.78 | TP53 (0.46) | TP53TDP1ALDH1A1TSHRFAAH | |
| SCHEMBL28846228 | 0.78 | TP53 (0.46) | TP53TDP1ALDH1A1TSHRFAAH | |
| SCHEMBL28202399 | 0.77 | TP53 (0.44) | TP53TDP1ALDH1A1TSHRFAAH | |
| SCHEMBL19931235 | 0.76 | TP53 (0.38) | TP53TDP1FAAH | |
| SCHEMBL6296630 | 0.75 | TP53 (0.43) | TP53TDP1ALDH1A1TSHRFAAH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10752721-B2 | Elastomeric copolymers based on [bis(trihydrocarbylsilyl)aminosilyl]-functionalized styrene and their use in the preparation of rubbers | SYNTHOS DWORY 7 SPOLKA Z ORGANICZONA ODPOWIEDZIALNOSCIA SPOLKA JAWNA (PL) | 2020-08-25 | — | — | US | disclosed |
| US-10723822-B2 | [Bis(trihydrocarbylsilyl)aminosilyl]-functionalized styrene and a method for its preparation | SYNTHOS DWORY 7 SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA SPOLKA JAWNA (PL) | 2020-07-28 | — | — | US | disclosed |
| US-20190256624-A1 | [BIS(TRIHYDROCARBYLSILYL)AMINOSILYL]-FUNCTIONALIZED STYRENE AND A METHOD FOR ITS PREPARATION | SYNTHOS DWORY 7 SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA (PL) | 2019-08-22 | — | — | US | disclosed |
| EP-3341424-B1 | ELASTOMERIC COPOLYMERS BASED ON [BIS(TRIHYDROCARBYLSILYL)AMINOSILYL]-FUNCTIONALIZED STYRENE AND THEIR USE IN THE PREPARATION OF RUBBERS | SYNTHOS DWORY 7 SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA SPOLKA JAWNA (PL) | 2019-03-13 | — | — | EP | disclosed |
| EP-3341423-B1 | [BIS(TRIHYDROCARBYLSILYL)AMINOSILYL]-FUNCTIONALIZED STYRENE AND A METHOD FOR ITS PREPARATION | Synthos Sa (PL) | 2018-12-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190256624-A1 | [BIS(TRIHYDROCARBYLSILYL)AMINOSILYL]-FUNCTIONALIZED STYRENE AND A METHOD FOR ITS PREPARATION | ADSL, PARN, STS | TP53 3767/4885TDP1 2488/4885ALDH1A1 1581/4885 |
| US-10723822-B2 | [Bis(trihydrocarbylsilyl)aminosilyl]-functionalized styrene and a method for its preparation | ADSL, PARN, STS | TP53 3767/4885TDP1 2488/4885ALDH1A1 1581/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.